materials on the wave of popularity of homeopathy in the United
Kingdom, whose government has reduced public funding for
Some centers prescribing a "soft" treatment, and favorable winds,
blowing in India, where the market is growing at 25% per year, supported by 100 million patients.
These insinuations responsible Laboratoires Boiron, the French homeopathic
pharmaceutical company, one of the largest enterprises in the sector, which
gives the results of experiments carried out in accordance with a valid
methodological point of view asles. Experiments have shown "good
effect of treatment of homeopathic remedies. " "The next attack is not worthy of
justify from a scientific point of view, reflecting the positions that are not conducive
advancement of knowledge. Homeopathy - the only tase chance for tomorrow's medicine
of the day - says the French company - but she can not develop in
alone, it requires support from scientists, academics,
practitioners.
In Italy, as the controversy unfolded after the publication in the latest issue
Newsletter instasment Italian pharmaceutical company Sif. In addition to
Homeopathy ("results of the studies demonstrate a low efficiency
homeopathic medicines and show negative results of treatment ")
sharply criticized acupuncture ("reasonable efficiency, for example,
cases of chronic inflammatory pathologies), the traditional Chinese
medicine (on this medicine have very limited information because of
complexities associated with the language), and herbal medicine. Was less rigid judgments about
Grass: "For years, many doctors in Italy are used herbs. However, evidence
on the effectiveness of their use is not always encouraging, and if the grass
prescribed too lightly, they can cause harm. "
Achille Caputo, president of Sif, explains the position of Pharmacology: "For
Health came the moment of great economic difficulty, and we do not
understand why they should pay for treatments that are not benefiting, which
described in the bill currently under discussion in Parliament. " "Some
200 hospital centers and territorial health departments to pay
other treatments, due to the independence of Italy in terms of
costs.
According to recent studies conducted by Istat in 2005,
When interviewed 60,000 families, the popularity of alternative treatments in
Italy first began to decline. At least once an alternative
methods of treatment of colds, flu, pain in the gut or rheumatic pain 7.9
million Italians - it's a million fewer than in 1999. The reason? Italians
began to exercise greater caution after a very promising research is not
publications.
Source: Inopressa.com